$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 139.96 | 8,536 | 1,194,724 | 68,729 | 77.3 K to 68.7 K (-11.05 %) |
May 07 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 71.17 | 44,939 | 3,198,309 | 0 | |
May 07 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 137.00 | 44,939 | 6,156,643 | 40,152 | 85.1 K to 40.2 K (-52.81 %) |
May 07 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 71.17 | 44,939 | 3,198,309 | 85,091 | 40.2 K to 85.1 K (+111.92 %) |
Apr 02 2021 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 326 | 0 | 10,639 | |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 115.42 | 25,887 | 2,987,878 | 284,427 | 310.3 K to 284.4 K (-8.34 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Grant | A | 115.42 | 58,368 | 6,736,835 | 310,314 | 251.9 K to 310.3 K (+23.17 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 120.47 | 5,574 | 671,500 | 40,152 | 45.7 K to 40.2 K (-12.19 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 115.42 | 4,217 | 486,726 | 45,726 | 49.9 K to 45.7 K (-8.44 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 115.42 | 9,791 | 1,130,077 | 49,943 | 40.2 K to 49.9 K (+24.38 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 115.42 | 684 | 78,947 | 26,802 | 27.5 K to 26.8 K (-2.49 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 115.42 | 1,884 | 217,451 | 27,485 | 25.6 K to 27.5 K (+7.36 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 115.42 | 6,403 | 739,034 | 88,792 | 95.2 K to 88.8 K (-6.73 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 115.42 | 17,322 | 1,999,305 | 95,195 | 77.9 K to 95.2 K (+22.24 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 115.42 | 5,066 | 584,718 | 77,265 | 82.3 K to 77.3 K (-6.15 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 115.42 | 11,299 | 1,304,131 | 82,331 | 71 K to 82.3 K (+15.91 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 115.42 | 8,334 | 961,910 | 49,931 | 58.3 K to 49.9 K (-14.30 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 115.42 | 16,570 | 1,912,509 | 58,265 | 41.7 K to 58.3 K (+39.74 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 115.42 | 6,165 | 711,564 | 30,250 | 36.4 K to 30.3 K (-16.93 %) |
Mar 11 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 115.42 | 13,181 | 1,521,351 | 36,394 | 23.2 K to 36.4 K (+56.78 %) |
Mar 01 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 115.49 | 801 | 92,507 | 40,152 | 41 K to 40.2 K (-1.96 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 121.19 | 806 | 97,679 | 41,695 | 42.5 K to 41.7 K (-1.90 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 121.15 | 1,250 | 151,438 | 42,501 | 43.8 K to 42.5 K (-2.86 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 121.19 | 103 | 12,483 | 25,601 | 25.7 K to 25.6 K (-0.40 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 121.15 | 159 | 19,263 | 25,704 | 25.9 K to 25.7 K (-0.61 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 121.19 | 611 | 74,047 | 23,213 | 23.8 K to 23.2 K (-2.56 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 121.15 | 1,017 | 123,210 | 23,824 | 24.8 K to 23.8 K (-4.09 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 121.19 | 541 | 65,564 | 77,873 | 78.4 K to 77.9 K (-0.69 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 121.15 | 830 | 100,555 | 78,414 | 79.2 K to 78.4 K (-1.05 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 121.19 | 3,319 | 402,230 | 251,946 | 255.3 K to 251.9 K (-1.30 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 121.15 | 4,033 | 488,598 | 255,265 | 259.3 K to 255.3 K (-1.56 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.19 | 524 | 63,504 | 71,032 | 71.6 K to 71 K (-0.73 %) |
Feb 25 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 121.15 | 796 | 96,435 | 71,556 | 72.4 K to 71.6 K (-1.10 %) |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
Feb 22 2021 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Grant | A | 0.00 | 4,926 | 0 | 29,045 | 24.1 K to 29 K (+20.42 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | A | 121.81 | 120,901 | 14,726,346 | 120,901 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Grant | A | 0.00 | 21,551 | 0 | 259,298 | 237.7 K to 259.3 K (+9.06 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 121.81 | 17,958 | 2,187,374 | 17,958 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 3,202 | 0 | 43,289 | 40.1 K to 43.3 K (+7.99 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | A | 121.81 | 4,003 | 487,585 | 4,003 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Grant | A | 0.00 | 715 | 0 | 25,863 | 25.1 K to 25.9 K (+2.84 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | A | 121.81 | 31,774 | 3,870,232 | 31,774 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 0.00 | 5,665 | 0 | 79,244 | 73.6 K to 79.2 K (+7.70 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | A | 121.81 | 22,105 | 2,692,500 | 22,105 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 0.00 | 3,941 | 0 | 72,352 | 68.4 K to 72.4 K (+5.76 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Option Exercise | A | 121.81 | 31,774 | 3,870,232 | 31,774 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 0.00 | 5,665 | 0 | 43,751 | 38.1 K to 43.8 K (+14.87 %) |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Option Exercise | A | 121.81 | 27,633 | 3,365,838 | 27,633 | |
Feb 19 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Grant | A | 0.00 | 4,926 | 0 | 24,841 | 19.9 K to 24.8 K (+24.74 %) |
Jan 07 2021 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 264 | 0 | 10,313 | |
Jan 07 2021 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Payment of Exercise | F | 119.00 | 2,640 | 314,160 | 19,896 | 22.5 K to 19.9 K (-11.71 %) |
Dec 28 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | M | 66.51 | 81,756 | 5,437,592 | 0 | |
Dec 28 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 121.18 | 22,563 | 2,734,139 | 73,579 | 96.1 K to 73.6 K (-23.47 %) |
Dec 28 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 120.06 | 59,193 | 7,106,534 | 96,142 | 155.3 K to 96.1 K (-38.11 %) |
Dec 28 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Buy | M | 66.51 | 81,756 | 5,437,592 | 155,335 | 73.6 K to 155.3 K (+111.11 %) |
Nov 27 2020 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 57.67 | 6,111 | 352,391 | 0 | |
Nov 27 2020 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 126.02 | 6,111 | 770,120 | 16,482 | 22.6 K to 16.5 K (-27.05 %) |
Nov 27 2020 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 57.67 | 6,111 | 352,391 | 22,593 | 16.5 K to 22.6 K (+37.08 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 127.45 | 2,300 | 293,137 | 28,349 | 30.6 K to 28.3 K (-7.50 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 126.46 | 3,302 | 417,584 | 30,649 | 34 K to 30.6 K (-9.73 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 125.73 | 5,621 | 706,738 | 33,951 | 39.6 K to 34 K (-14.20 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 127.45 | 2,300 | 293,137 | 28,349 | 30.6 K to 28.3 K (-7.50 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 126.46 | 3,302 | 417,584 | 30,649 | 34 K to 30.6 K (-9.73 %) |
Nov 24 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 125.73 | 5,621 | 706,738 | 33,951 | 39.6 K to 34 K (-14.20 %) |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | M | 57.61 | 5,700 | 328,349 | 0 | |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Option Exercise | M | 56.82 | 4,750 | 269,895 | 0 | |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Sell | S | 125.00 | 4,750 | 593,750 | 25,090 | 29.8 K to 25.1 K (-15.92 %) |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Sell | S | 125.00 | 5,700 | 712,500 | 29,785 | 35.5 K to 29.8 K (-16.06 %) |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Buy | M | 57.61 | 5,700 | 328,349 | 35,485 | 29.8 K to 35.5 K (+19.14 %) |
Oct 23 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Buy | M | 56.82 | 4,750 | 269,895 | 29,785 | 25 K to 29.8 K (+18.97 %) |
Oct 19 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | M | 66.51 | 291,997 | 19,420,720 | 0 | |
Oct 19 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 120.00 | 291,997 | 35,039,640 | 237,747 | 529.7 K to 237.7 K (-55.12 %) |
Oct 19 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Buy | M | 66.51 | 291,997 | 19,420,720 | 529,744 | 237.7 K to 529.7 K (+122.82 %) |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 52.17 | 35,591 | 1,856,605 | 0 | |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 119.00 | 35,591 | 4,235,329 | 40,087 | 75.7 K to 40.1 K (-47.03 %) |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 52.17 | 35,591 | 1,856,605 | 75,678 | 40.1 K to 75.7 K (+88.78 %) |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 52.17 | 35,591 | 1,856,605 | 0 | |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 119.00 | 35,591 | 4,235,329 | 40,087 | 75.7 K to 40.1 K (-47.03 %) |
Oct 15 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 52.17 | 35,591 | 1,856,605 | 75,678 | 40.1 K to 75.7 K (+88.78 %) |
Oct 07 2020 | DGX | QUEST DIAGNOSTICS ... | Mendez Manuel O. | SVP & Chief Commerc ... | Payment of Exercise | F | 114.01 | 5,871 | 669,353 | 23,982 | 29.9 K to 24 K (-19.67 %) |
Oct 05 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 270 | 0 | 10,005 | |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Option Exercise | M | 66.51 | 58,392 | 3,883,652 | 0 | |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 111.13 | 3,776 | 419,616 | 68,411 | 72.2 K to 68.4 K (-5.23 %) |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 110.57 | 54,616 | 6,038,727 | 72,187 | 126.8 K to 72.2 K (-43.07 %) |
Sep 04 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Buy | M | 66.51 | 58,392 | 3,883,652 | 126,803 | 68.4 K to 126.8 K (+85.35 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Option Exercise | M | 71.17 | 72,596 | 5,166,657 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 118.60 | 8,524 | 1,010,980 | 73,579 | 82.1 K to 73.6 K (-10.38 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 117.65 | 18,246 | 2,146,624 | 82,103 | 100.3 K to 82.1 K (-18.18 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Sell | S | 116.81 | 45,826 | 5,352,981 | 100,349 | 146.2 K to 100.3 K (-31.35 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Buy | M | 71.17 | 72,596 | 5,166,657 | 146,175 | 73.6 K to 146.2 K (+98.66 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 63.42 | 779 | 49,404 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 60.22 | 790 | 47,570 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 57.57 | 6,111 | 351,780 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 61.62 | 820 | 50,524 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 58.37 | 151 | 8,814 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 58.37 | 532 | 31,053 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | M | 57.74 | 2,547 | 147,064 | 0 | |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Sell | S | 116.60 | 11,730 | 1,367,718 | 20,505 | 32.2 K to 20.5 K (-36.39 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 63.42 | 779 | 49,404 | 32,235 | 31.5 K to 32.2 K (+2.48 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 60.22 | 790 | 47,570 | 31,456 | 30.7 K to 31.5 K (+2.58 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 57.57 | 6,111 | 351,780 | 30,666 | 24.6 K to 30.7 K (+24.89 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 61.62 | 820 | 50,524 | 24,555 | 23.7 K to 24.6 K (+3.45 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 58.37 | 151 | 8,814 | 23,735 | 23.6 K to 23.7 K (+0.64 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 58.37 | 532 | 31,053 | 23,584 | 23.1 K to 23.6 K (+2.31 %) |
Jun 10 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Buy | M | 57.74 | 2,547 | 147,064 | 23,052 | 20.5 K to 23.1 K (+12.42 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | Lassiter Wright III | Director | Grant | A | 0.00 | 1,531 | 0 | 1,882 | 351 to 1.9 K (+436.18 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,531 | 0 | 16,482 | 15 K to 16.5 K (+10.24 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,531 | 0 | 39,572 | 38 K to 39.6 K (+4.02 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Grant | A | 0.00 | 1,531 | 0 | 20,505 | 19 K to 20.5 K (+8.07 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 1,531 | 0 | 21,513 | 20 K to 21.5 K (+7.66 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | MAIN TIMOTHY L | Director | Grant | A | 0.00 | 1,531 | 0 | 19,588 | 18.1 K to 19.6 K (+8.48 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | Torley Helen | Director | Grant | A | 0.00 | 1,531 | 0 | 4,897 | 3.4 K to 4.9 K (+45.48 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | Gregg Vicky B | Director | Grant | A | 0.00 | 1,531 | 0 | 13,844 | 12.3 K to 13.8 K (+12.43 %) |
May 21 2020 | DGX | QUEST DIAGNOSTICS ... | MORRISON DENISE M | Director | Grant | A | 0.00 | 1,531 | 0 | 3,783 | 2.3 K to 3.8 K (+67.98 %) |
May 20 2020 | DGX | QUEST DIAGNOSTICS ... | DEPPE MICHAEL J | VP, Corp. Controlle ... | Payment of Exercise | F | 107.42 | 5 | 537 | 25,035 | 25 K to 25 K (-0.02 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | M | 71.17 | 11,717 | 833,899 | 0 | |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | M | 71.17 | 11,717 | 833,899 | 0 | |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 112.01 | 11,717 | 1,312,433 | 237,747 | 249.5 K to 237.7 K (-4.70 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 112.01 | 11,717 | 1,312,433 | 237,747 | 249.5 K to 237.7 K (-4.70 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Buy | M | 71.17 | 11,717 | 833,899 | 249,464 | 237.7 K to 249.5 K (+4.93 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Buy | M | 71.17 | 11,717 | 833,899 | 249,464 | 237.7 K to 249.5 K (+4.93 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Sell | S | 110.00 | 2,500 | 275,000 | 22,390 | 24.9 K to 22.4 K (-10.04 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Sell | S | 110.00 | 2,500 | 275,000 | 22,390 | 24.9 K to 22.4 K (-10.04 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Sell | S | 112.03 | 2,500 | 280,075 | 24,890 | 27.4 K to 24.9 K (-9.13 %) |
Apr 28 2020 | DGX | QUEST DIAGNOSTICS ... | EGLINTON MANNER CARRIE | SVP, Advanced Diagn ... | Sell | S | 112.03 | 2,500 | 280,075 | 24,890 | 27.4 K to 24.9 K (-9.13 %) |
Apr 03 2020 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 0.00 | 403 | 0 | 9,434 | |
Mar 17 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 90.15 | 500 | 45,073 | 38,086 | 38.6 K to 38.1 K (-1.30 %) |
Mar 17 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 88.53 | 421 | 37,269 | 38,586 | 39 K to 38.6 K (-1.08 %) |
Mar 17 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 87.81 | 1,307 | 114,772 | 39,007 | 40.3 K to 39 K (-3.24 %) |
Mar 17 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 86.65 | 1,085 | 94,020 | 40,314 | 41.4 K to 40.3 K (-2.62 %) |
Mar 17 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Sell | S | 85.59 | 200 | 17,118 | 41,399 | 41.6 K to 41.4 K (-0.48 %) |
Mar 16 2020 | DGX | QUEST DIAGNOSTICS ... | Lassiter Wright III | Director | Grant | A | 0.00 | 351 | 0 | 351 | 0 to 351 |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Payment of Exercise | F | 106.46 | 3,846 | 409,445 | 41,599 | 45.4 K to 41.6 K (-8.46 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Davis J. E. | EVP, General Diagno ... | Grant | A | 106.46 | 7,359 | 783,439 | 45,445 | 38.1 K to 45.4 K (+19.32 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 104.25 | 2,175 | 226,744 | 40,087 | 42.3 K to 40.1 K (-5.15 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 106.46 | 2,174 | 231,444 | 42,262 | 44.4 K to 42.3 K (-4.89 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 106.46 | 4,349 | 462,995 | 44,436 | 40.1 K to 44.4 K (+10.85 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Payment of Exercise | F | 106.46 | 3,870 | 412,000 | 73,579 | 77.4 K to 73.6 K (-5.00 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | GUINAN MARK | Executive Vice Pres ... | Grant | A | 106.46 | 7,693 | 818,997 | 77,449 | 69.8 K to 77.4 K (+11.03 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Sell | S | 104.25 | 2,501 | 260,729 | 68,411 | 70.9 K to 68.4 K (-3.53 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Payment of Exercise | F | 106.46 | 2,517 | 267,960 | 70,912 | 73.4 K to 70.9 K (-3.43 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Group Exec. Cl ... | Grant | A | 106.46 | 5,018 | 534,216 | 73,429 | 68.4 K to 73.4 K (+7.34 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Option Exercise | M | 71.17 | 100 | 7,117 | 11,717 | |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Sell | S | 112.19 | 100 | 11,219 | 237,747 | 237.8 K to 237.7 K (-0.04 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Buy | M | 71.17 | 100 | 7,117 | 237,847 | 237.7 K to 237.8 K (+0.04 %) |
Mar 12 2020 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | Chairman, CEO and P ... | Payment of Exercise | F | 106.46 | 13,898 | 1,479,581 | 237,747 | 251.6 K to 237.7 K (-5.52 %) |